Meitar represented NYSE-listed Covidien, a US medical device manufacture, in its acquisition of Given Imaging, a medical technology company that develops and manufactures the swallowable imaging capsules for endoscopy, for approximately $1 billion.
Meitar, together with Gibson Dunn, represented US enterprise data giant EMC in its acquisition of Scale IO, an Israeli start up and a leader in enterprise data storage.
Our firm represented Cimatron (NASDAQ:CIMT), a leading global provider of integrated CAD/CAM software solutions for the tool making and manufacturing industries, in its $15.7 million secondary and $6.2 million follow-on public offerings of Ordinary Shares on NASDAQ.
Meitar defended Makhteshim, one of Israel’s largest agrochemicals producers, in three mass tort actions filed by plaintiffs alleging injuries caused by air pollution from the Makhteshim plant in the “Ramat-Hovav” Industrial Zone south of Beersheva (additional defendants in this action included the State of Israel, the local municipality and other plants in the area). On January 1, 2013 the Beersheva District Court dismissed the actions in their entirety and made significant awards to the defendants for legal costs and attorneys fees. The plaintiffs have filed an appeal with the Supreme Court, which is pending.
Our firm represented Needham & Company and Oppenheimer & Co in the $32 million ordinary shares of Ceragon Networks on NASDAQ.
Meitar successfully represented Israeli cellular operators Partner and Cellcom in opposing motions to certify class actions against them related to the battery life of cellular devices. The motions were withdrawn.
Meitar represented Sapiens (TASE and NASDAQ: SPNS), a leading global provider of software solutions for the insurance industry, in its $40 million public offering.
